Jo Perry
Jo Perry
Liggins Institute, Auckland
Verified email at
Cited by
Cited by
In vivo and in vitro swelling of cell walls during fruit ripening
RJ Redgwell, E MacRae, I Hallett, M Fischer, J Perry, R Harker
Planta 203, 162-173, 1997
Human centromere repositioning “in progress”
DJ Amor, K Bentley, J Ryan, J Perry, L Wong, H Slater, KHA Choo
Proceedings of the National Academy of Sciences 101 (17), 6542-6547, 2004
The oncogenic potential of growth hormone
JK Perry, BS Emerald, HC Mertani, PE Lobie
Growth hormone & IGF research 16 (5-6), 277-289, 2006
A short pseudoautosomal region in laboratory mice
J Perry, S Palmer, A Gabriel, A Ashworth
Genome research 11 (11), 1826-1832, 2001
Are trefoil factors oncogenic?
JK Perry, N Kannan, PM Grandison, MD Mitchell, PE Lobie
Trends in Endocrinology & Metabolism 19 (2), 74-81, 2008
Evolutionary rate of a gene affected by chromosomal position
J Perry, A Ashworth
Current biology 9 (17), 987-S3, 1999
Artemin is oncogenic for human mammary carcinoma cells
J Kang, JK Perry, V Pandey, GC Fielder, B Mei, PX Qian, ZS Wu, T Zhu, ...
Oncogene 28 (19), 2034-2045, 2009
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells
V Pandey, JK Perry, KM Mohankumar, XJ Kong, SM Liu, ZS Wu, ...
Endocrinology 149 (8), 3909-3919, 2008
Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma
SE Brunet-Dunand, C Vouyovitch, S Araneda, V Pandey, LJP Vidal, ...
Endocrinology 150 (3), 1341-1352, 2009
The contribution of growth hormone to mammary neoplasia
JK Perry, KM Mohankumar, BS Emerald, HC Mertani, PE Lobie
Journal of mammary gland biology and neoplasia 13 (1), 131-145, 2008
Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma
ZS Wu, K Yang, Y Wan, PX Qian, JK Perry, J Chiesa, HC Mertani, T Zhu, ...
The Journal of Clinical Endocrinology & Metabolism 96 (10), E1619-E1629, 2011
Autocrine/paracrine human growth hormone-stimulated MicroRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer
W Zhang, P Qian, X Zhang, M Zhang, H Wang, M Wu, X Kong, S Tan, ...
Journal of Biological Chemistry 290 (22), 13812-13829, 2015
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma
N Kannan, J Kang, X Kong, J Tang, JK Perry, KM Mohankumar, LD Miller, ...
Neoplasia (New York, NY) 12 (12), 1041, 2010
Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells
N Amiry, X Kong, N Muniraj, N Kannan, PM Grandison, J Lin, Y Yang, ...
Endocrinology 150 (10), 4473-4483, 2009
Targeting growth hormone function: strategies and therapeutic applications
M Lu, JU Flanagan, RJ Langley, MP Hay, JK Perry
Signal transduction and targeted therapy 4 (1), 1-11, 2019
Growth hormone and cancer: an update on progress
JK Perry, DX Liu, ZS Wu, T Zhu, PE Lobie
Current Opinion in Endocrinology, Diabetes and Obesity 20 (4), 307-313, 2013
The genetic architecture of type 1 diabetes mellitus
DM Nyaga, MH Vickers, C Jefferies, JK Perry, JM O'Sullivan
Molecular and cellular endocrinology 477, 70-80, 2018
A gene spans the pseudoautosomal boundary in mice
S Palmer, J Perry, D Kipling, A Ashworth
Proceedings of the National Academy of Sciences 94 (22), 12030-12035, 1997
The Y* rearrangement in mice: new insights into a perplexing PAR.
PS Burgoyne, SK Mahadevaiah, J Perry, SJ Palmer, A Ashworth
Cytogenetics and cell genetics 80 (1-4), 37-40, 1997
Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells
V Pandey, PX Qian, J Kang, JK Perry, MD Mitchell, Z Yin, ZS Wu, DX Liu, ...
Endocrinology 151 (3), 909-920, 2010
The system can't perform the operation now. Try again later.
Articles 1–20